John V. Reynolds

24.3k total citations · 1 hit paper
502 papers, 14.2k citations indexed

About

John V. Reynolds is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, John V. Reynolds has authored 502 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 345 papers in Surgery, 175 papers in Pulmonary and Respiratory Medicine and 127 papers in Oncology. Recurrent topics in John V. Reynolds's work include Esophageal Cancer Research and Treatment (230 papers), Esophageal and GI Pathology (120 papers) and Gastric Cancer Management and Outcomes (109 papers). John V. Reynolds is often cited by papers focused on Esophageal Cancer Research and Treatment (230 papers), Esophageal and GI Pathology (120 papers) and Gastric Cancer Management and Outcomes (109 papers). John V. Reynolds collaborates with scholars based in Ireland, United Kingdom and United States. John V. Reynolds's co-authors include Claire L. Donohoe, Joanne Lysaght, Suzanne L. Doyle, Narayanasamy Ravi, Aoife M. Ryan, Graham P. Pidgeon, Stephen G. Maher, Niamh Lynam‐Lennon, Dermot Kelleher and Jacintha O’Sullivan and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

John V. Reynolds

481 papers receiving 13.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Climate change and the global pattern of moraine-dammed glacial lake outburst floods

2018 255 citations Stephan Harrison, Jeffrey S. Kargel et al. The cryosphere profile →

Peers

Countries citing papers authored by John V. Reynolds

Since Specialization

Citations

This map shows the geographic impact of John V. Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John V. Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John V. Reynolds more than expected).

Fields of papers citing papers by John V. Reynolds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John V. Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John V. Reynolds. The network helps show where John V. Reynolds may publish in the future.

Co-authorship network of co-authors of John V. Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of John V. Reynolds. A scholar is included among the top collaborators of John V. Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John V. Reynolds. John V. Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma 2024 ·Biomedicines ·Maria Davern, (unknown), Noel E. Donlon, (unknown), (unknown), (unknown), (unknown), Dara Bracken‐Clarke, Christine Butler, Narayanasamy Ravi, Claire L. Donohoe, John V. Reynolds, Joanne Lysaght, Melissa J. Conroy	2
2	143. NEOADJUVANT CHEMORADIOTHERAPY VERSUS CHEMOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA IN THE EUROPEAN MULTICENTER ENSURE STUDY 2023 ·Diseases of the Esophagus ·Jessie A. Elliott, Fredrik Klevebro, Styliani Mantziari, Sheraz R. Markar, Lucas Goense, Asif Johar, Pernilla Lagergren, Giovanni Zaninotto, Richard van Hillegersberg, Mark I. van Berge Henegouwen, Markus Schäfer, Magnus Nilsson, George B. Hanna, John V. Reynolds, (unknown)	1
3	PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours 2022 ·Translational Oncology ·Maria Davern, (unknown), (unknown), (unknown), Noel E. Donlon, (unknown), (unknown), (unknown), Conall Hayes, Jamie Macdonald, (unknown), John V. Reynolds, Stephen G. Maher, Niamh Lynam‐Lennon, Brona M. Murphy, Joanne Lysaght	6
4	Telehealth Delivery of a Multi-Disciplinary Rehabilitation Programme for Upper Gastro-Intestinal Cancer: ReStOre@Home Feasibility Study 2022 ·Cancers ·Louise Brennan, Fatemeh Sadeghi, Linda O’Neill, Emer Guinan, (unknown), Gráinne Sheill, Emily Nash Smyth, Suzanne L. Doyle, Claire Timon, Deirdre Connolly, Jacintha O’Sullivan, John V. Reynolds, Juliette Hussey	18
5	Successful maintenance of process and outcomes for oesophageal cancer surgery in Ireland during the first wave of the COVID-19 pandemic 2021 ·Irish Journal of Medical Science (1971 -) ·Jarlath Bolger, Noel E. Donlon, Waqas Butt, (unknown), (unknown), (unknown), (unknown), (unknown), Mayilone Arumugasamy, Thomas J. Murphy, William B. Robb, Chris Collins, Paul Carroll, Claire L. Donohoe, Narayanasamy Ravi, John V. Reynolds	9
6	Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells 2021 ·Translational Oncology ·Maria Davern, Noel E. Donlon, (unknown), (unknown), Conall Hayes, (unknown), (unknown), Dermot O’Toole, Niamh Lynam‐Lennon, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Joanne Lysaght	12
7	Organ preservation in the multimodality approach to locally advanced oesophageal cancer:festina lente 2021 ·British journal of surgery ·Jarlath Bolger, John V. Reynolds	0
8	The tumour immune microenvironment in oesophageal cancer 2021 ·British Journal of Cancer ·Maria Davern, Noel E. Donlon, Robert Power, Conall Hayes, (unknown), Margaret R. Dunne, John V. Reynolds	27
9	Colonic interposition, a contemporary experience: technical aspects and outcomes 2020 ·Updates in Surgery ·Naomi Fearon, Helen Mohan, (unknown), Narayanasamy Ravi, John V. Reynolds	4
10	Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines 2020 ·Cancers ·Noel E. Donlon, (unknown), Maria Davern, Fiona O’Connell, J.J. Phelan, Robert Power, Timothy Nugent, (unknown), (unknown), John Greene, (unknown), (unknown), (unknown), Narayanasamy Ravi, Claire L. Donohoe, John V. Reynolds, Joanne Lysaght, Jacintha O’Sullivan, Margaret R. Dunne	15
11	CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies 2020 ·Cancer Immunology Immunotherapy ·Ashanty M. Melo, Melissa J. Conroy, (unknown), (unknown), Eamon P. Breen, John V. Reynolds, Joanne Lysaght, Derek G. Doherty	9
12	Quantifying postoperative mobilisation following oesophagectomy 2018 ·Physiotherapy ·Juliette Hussey, (unknown), Joanne Dowds, Louise O’Connor, John V. Reynolds, Emer Guinan	17
13	Climate change and the global pattern of moraine-dammed glacial lake outburst floods breakdown → 2018 ·The cryosphere ·Stephan Harrison, Jeffrey S. Kargel, Christian Huggel, John V. Reynolds, Dan H. Shugar, Richard Betts, Adam Emmer, Neil F. Glasser, Umesh K. Haritashya, Jan Klimeš, Liam Reinhardt, Yvonne Schaub, Andy Wiltshire, Dhananjay Regmi, Vít Vilímek	255
14	Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance 2017 ·Supportive Care in Cancer ·Emer Guinan, Suzanne L. Doyle, Annemarie E. Bennett, Linda O’Neill, (unknown), Jessie A. Elliott, Jacintha O’Sullivan, John V. Reynolds, Juliette Hussey	53
15	COX-Derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention 2012 ·Arrow@dit (Dublin Institute of Technology) ·John V. Reynolds, Jacintha O’Sullivan, (unknown), Graham P. Pidgeon, (unknown)	45
16	The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer 2010 ·Arrow@dit (Dublin Institute of Technology) ·Graham P. Pidgeon, John V. Reynolds, Kenneth J. O’Byrne	58
17	Nonsteroidal Anti-inflammatory Drugs and the Esophageal Inflammation-Metaplasia-Adenocarcinoma Sequence 2006 ·Cancer Research ·Lesley Anderson, Brian T. Johnston, R. G. P. Watson, Seamus Murphy, H. Ferguson, Harry Comber, Jim McGuigan, John V. Reynolds, Liam Murray	95
18	Low pH induces co-ordinate regulation of gene expression in oesophageal cells 2005 ·Carcinogenesis ·Shane P. Duggan, William M. Gallagher, Edward Fox, Mohamed Abdel-Latif, John V. Reynolds, Dermot Kelleher	49
19	Hepatic resection for colorectal metastases – a national perspective 2004 ·Annals of The Royal College of Surgeons of England ·(unknown), John V. Reynolds, (unknown), N D Karanjia	12
20	Heberden Society 1981 ·Annals of the Rheumatic Diseases ·Victoria Gibson, (unknown), (unknown), (unknown), R C G Russell, Gillian Murphy, John V. Reynolds, (unknown), J M Gumpel, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact